Ohioans will likely be able to buy recreational marijuana as soon as mid-June, earlier than the timeline outlined by the initiated statute they voted to pass last fall, and existing medical marijuana dispensaries say they plan to be prepared for the state’s non-medical green light.
The state’s joint committee on agency rule review (JCARR) meets May 13, when it’s scheduled to vote on its first batch of rules from the Ohio Department of Commerce’s Division of Cannabis Control. Among those are rules for the application process medical dispensaries need to go through to get licensed to sell to any of-age customer.
“I’ve been assured they will be reviewed very quickly once they are filled out and returned, and they will be fairly straightforward applications,” said Rep. Jamie Callender (R-Concord), who chairs the joint committee. “That being the case, we could have recreational sales as early as the second week of June.”
Ohio Cannabis Co. owner Brian Wingfield said a few regulatory snags delayed them from starting medical sales in 2019 by a few weeks.
“I really wish we would have been there on that opening day; it didn’t happen,” Wingfield said in an interview. “I want to be on opening day this time and so we’re working toward that.”
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
Founded in 2018, Michigan-based C3 Industries is a privately owned, vertically integrated cannabis company that has in short order expanded its retail, cultivation, and manufacturing operations from one state to…
By Aaron Pelley, Attorney at Harris Sliwoski The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the…
The Biden administration is expected to reclassify the federal government’s position on marijuana, shifting it from a Schedule I drug to a Schedule III drug, The Associated Press first reported. The change would…
As the Biden administration moves to reclassify marijuana as a less dangerous drug, scientists say the change will lift some of the restrictions on studying the drug. But the change…